Literature DB >> 13698307

[Alveolar myoblastic sarcoma of the skeletal musculature].

H G FASSBENDER.   

Abstract

Entities:  

Keywords:  MESENCHYMOMA/case reports; MUSCLES/neoplasms

Mesh：

Year:  1960        PMID： 13698307

Source DB:  PubMed          Journal:  Oncologia        ISSN： 0369-7606


× No keyword cloud information.
  8 in total

Review 1.  Primary alveolar soft part sarcoma of chest wall: a case report and review of the literature.

Authors:  Farhad Zamani; Mosadegh Jabbari; Seyed Maysom Alimohamadi; Ramin Shakeri; Zohreh Rostami; Behnoush Abedi; Mahshid Hormazdi; Reza Malekzadeh
Journal:  MedGenMed       Date:  2006-07-05

2.  [Treatment of alveolar soft part sarcoma (author's transl)].

Authors:  U Weber; K Havemann
Journal:  Arch Orthop Unfallchir       Date:  1977-08-26

3.  Alveolar soft-part sarcoma.

Authors:  R Hurt; M Bates; W Harrison
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

4.  Alveolar soft part sarcoma.

Authors:  Aarti Singh; Sunita Gupta; Sujoy Ghosh; Monal Bhaurao Yuwanati
Journal:  BMJ Case Rep       Date:  2014-04-10

5.  Alveolar soft part sarcoma metastasized to both the skull and the brain.

Authors:  Tae-Hee Shin; Young-Jin Jung; Oh-Lyong Kim; Min-Su Kim
Journal:  J Korean Neurosurg Soc       Date:  2012-07-31

6.  Alveolar Soft Part Sarcoma Metastasizing to the Brain: A Rare Entity Revisited with Review of Recent Literature.

Authors:  Singh Mathuria Kaushal-Deep; Uday Singh Raswan; Altaf Rehman Kirmani; Abdul Rashid Bhat; Irfan Hussain Bhat
Journal:  J Pediatr Neurosci       Date:  2019-09-27

7.  Alveolar soft part sarcoma of the frontal calvarium and adjacent frontal lobe.

Authors:  Kuntal K Das; Rohit K Singh; Sushila Jaiswal; Vinita Agrawal; Awadhesh K Jaiswal; Sanjay Behari
Journal:  J Pediatr Neurosci       Date:  2012-01

8.  Brain metastatic alveolar soft-part sarcoma: Clinicopathological profiles, management and outcomes.

Authors:  Xiaogang Tao; Zonggang Hou; Zhen Wu; Shuyu Hao; Baiyun Liu
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.